Previous 10 | Next 10 |
2024-06-18 03:05:48 ET Summary As of this article being written, Hims & Hers Health is up around 33% since the announcement that they will offer GLP-1 Injections for as low as $199 a month. Reports that the company has already started shipping out injections to subscribers. ...
2024-06-13 16:00:00 ET Summary HIMS has proven that a telehealth platform can remain relevant in a rapidly changing landscape, by opting to cater to the retail healthcare market through customized prescription/ over-the-counter medications. This is attributed to its in-house pharm...
Hims & Hers Health, Inc. (NYSE: HIMS) is the focus of IBN's latest stock spotlight. The company's shares have moved -0.97% on the day to $23.45. Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The com...
2024-06-10 15:47:28 ET Summary Hims & Hers has rallied substantially this year as it started to show its profitability chops. Despite guiding for a >$1 billion annualized revenue scale in 2024, the company is still expected to grow revenue north of 40%+ and have 80%+ pro fo...
2024-06-10 12:06:11 ET Summary Hims & Hers stock has easily outperformed the market over the past year, surging almost 130%. Hims & Hers' personalized care platform is a critical growth driver poised to expand further. Hims & Hers is targeting the weight loss drugs...
2024-06-10 04:41:47 ET Summary Hims & Hers boasts booming revenue, but faces a commoditized business model with intense competition. High marketing expenses raise concerns about customer retention and unit economics. Decelerating revenue growth, potential margin contractio...
Shares of Hims & Hers Health, Inc. (NYSE: HIMS) traded at a new 52-week high today and are currently trading at $21.34. So far today, approximately 2.35M shares have been exchanged, as compared to an average 30-day volume of 14.09M shares. Hims & Hers Health, Inc. operates a multi-spe...
2024-06-01 09:22:00 ET Shares of Hims & Hers Health (NYSE: HIMS) rocketed 23% higher this week. The telehealth platform that is focused on making getting treatment affordable and streamlined seems to still be riding high on its recent announcement of adding weight loss drugs to ...
2024-05-30 13:17:18 ET DENVER, Colo., May 30, 2024 ( 247marketnews.com )- Brera Holdings PLC (Nasdaq:BREA), Sharps Technology, Inc. (NASDAQ:STSS), OneMedNet Corporation (Nasdaq:ONMD), Momentus Inc. (NASDAQ:MNTS), Faraday Future Intelligent Electric (Nasdaq: FFIE), Hims & Hers Heal...
2024-05-28 11:05:25 ET More on Consumer Staples XLP: Not In The Spotlight Amid Market Uncertainty XLP: Expensive With Underperformance Risk XLP: Rotate Into This Lagging Sector The consumer 'remains more likely to cruise' than crumble - Goldman Sachs ...
News, Short Squeeze, Breakout and More Instantly...
Hims & Hers Health Inc. Class A Company Name:
HIMS Stock Symbol:
NYSE Market:
Hims & Hers Health Inc. Class A Website:
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading hea...
2024-07-20 09:00:00 ET With shares up a blistering 150% year to date, Hims & Hers Health (NYSE: HIMS) boasts everything an investor could dream of these days: rapid expansion, a vast addressable market, and a reasonable valuation. Let's explore why it is my top growth ...
Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...